These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 917453)

  • 1. Lewis lung tumor system as a model for studying the immune function in syngeneic in equillibrium allogeneic chimeras.
    Elbling L; Kurata T; Micksche M
    Oncology; 1977; 34(5):209-11. PubMed ID: 917453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumor growth in chimeric mice.
    Elbling L; Kurata T; Micksche M
    Oncology; 1976; 33(4):157-60. PubMed ID: 1087971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. II. Correlation with BCG activity in syngeneic tumor systems.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1978 May; 60(5):1069-73. PubMed ID: 305966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor.
    Martin WJ; Esber E; Cotton WG; Rice JM
    J Immunol; 1975 Jul; 115(1):289-295. PubMed ID: 50354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor acceptance modified by passage in hybrids with graft-versus-host reaction.
    Jacobs BB; Parks RC
    Exp Hematol; 1978 Nov; 6(10):785-90. PubMed ID: 33818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of immunologic competence of the host on metastases induced by the 3LL Lewis tumor in mice.
    Carnaud C; Hoch B; Trainin N
    J Natl Cancer Inst; 1974 Feb; 52(2):395-9. PubMed ID: 4816002
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of mitogen responses and graft-versus-host reaction by splenocytes from mice bearing Lewis lung carcinoma.
    Anaclerio A; Moras ML; Conti G; Mistrello G; Spreafico F
    J Natl Cancer Inst; 1978 Aug; 61(2):471-5. PubMed ID: 28421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.
    Van Pel A; Georlette M; Boon T
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5282-5. PubMed ID: 291945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of immune response with clinical stage in Lewis lung tumor-bearing mice.
    Kurata T; Micksche M
    Oncology; 1978; 35(4):155-9. PubMed ID: 704036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the rejection of an allogeneic tumor graft in two strains of inbred mice and their F1 hybrids.
    Turianskyj FH; Gyenes L
    Immunol Commun; 1974; 3(6):565-75. PubMed ID: 4452575
    [No Abstract]   [Full Text] [Related]  

  • 14. Strain specific transplantable medullar carcinoma in DBA/2W mice.
    Włodarski K; Mazur S
    Arch Immunol Ther Exp (Warsz); 1983; 31(2):255-60. PubMed ID: 6651482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response.
    Schirrmacher V; Landolfo S; Zawatzky R; Kirchner H
    Invasion Metastasis; 1981; 1(3):175-94. PubMed ID: 6821364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic tumor-syngeneic muscle sandwich grafts: a method for promoting nonspecific growth.
    Parks RC
    J Natl Cancer Inst; 1976 Jun; 56(6):1281-4. PubMed ID: 994227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interleukin-6 on hematopoiesis in allogeneic and syngeneic bone marrow chimeras.
    Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi M; Kobayashi S; Tanaka J; Kasai M; Sakurada K
    Immunobiology; 1994 Aug; 191(1):21-37. PubMed ID: 7806257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.